Nervonik develops a peripheral nerve stimulation (PNS) platform designed for high‑motion use, combining durable lead architecture, high‑bandwidth wireless connectivity, and integrated biosensing. The patented trifecta technology provides clinicians with objective feedback for more precise lead placement, data‑driven programming, and improved energy efficiency, aiming to deliver reliable long‑term pain relief for active patients.
Funding
$13M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
1OFounders
Product
Problem
Current peripheral nerve stimulation (PNS) devices are built for low‑motion environments, resulting in lead instability, limited connectivity, and an inability to provide objective biosensing feedback during active use. This hampers accurate lead placement, optimal programming, and long‑term efficacy for patients who need pain relief while maintaining an active lifestyle.
Solution
Nervonik is developing a next‑generation PNS platform engineered to withstand high‑motion conditions. The system incorporates a patented “trifecta” technology that combines robust lead stability, high‑bandwidth wireless connectivity, and integrated biosensing capabilities. By delivering reliable signal quality during dynamic activity, the platform enables clinicians to place leads more precisely, program therapies with data‑driven adjustments, and achieve greater energy efficiency. Objective feedback from the device supports smarter therapy management and aims to improve long‑term pain relief outcomes for active patients.
Target Audience
Primary customers are pain management physicians, neuromodulation clinics, and healthcare providers treating chronic pain patients who require a PNS solution compatible with active, high‑motion lifestyles.
Features
- Durable, motion‑resistant lead architecture designed to maintain consistent contact during vigorous movement
- High‑speed, low‑latency wireless connectivity for real‑time data transmission and remote programming
- Integrated biosensing suite that captures electrophysiological signals to inform lead placement and therapy adjustments
- Patented trifecta technology that unifies lead stability, connectivity, and sensing into a single platform
- Energy‑efficient stimulation algorithms that extend device battery life while delivering effective therapy
- Modular, wearable form factor suitable for use in everyday activities and clinical settings